Dolby Laboratories earnings release, July 30, 2026
Dolby Laboratories Reports Third Quarter 2026 Financial Results
SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026.
“We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “We are expanding our total addressable market and creating new opportunities with content partners through the Video Distribution Program and Dolby OptiView, and we continue to bring Dolby Atmos and Dolby Vision to more experiences from live sports, to music in the car, to user-generated content on mobile devices and more.”
Third Quarter Fiscal 2026 Financial Highlights
A complete listing of Dolby’s non-GAAP measures is described and reconciled to the corresponding GAAP measures at the end of this release.
Recent Business Highlights
Dividend
Today, Dolby announced a cash dividend of $0.36 per share of Class A and Class B common stock, payable on August 19, 2026, to stockholders of record as of the close of business on August 11, 2026.
Stock Repurchase Program
Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of its Class A Common Stock to approximately $427 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that the company considers appropriate.
Financial Outlook
Financial statements
Income Statement
Fiscal Quarter Ended — ) (in thousands)
| Fiscal Quarter Ended – June 26, 2026 | Fiscal Quarter Ended – June 27, 2025 | Fiscal Year-To-Date Ended – June 26, 2026 | Fiscal Year-To-Date Ended – June 27, 2025 | ||
|---|---|---|---|---|---|
| Revenue: | Licensing | 282,351 | 289,905 | 974,367 | 966,390 |
| Revenue: | Products and services | 22,644 | 25,641 | 72,964 | 75,716 |
| Revenue: | Total revenue | 304,995 | 315,546 | 1,047,331 | 1,042,106 |
| Cost of revenue: | Cost of licensing | 22,718 | 21,713 | 67,523 | 62,508 |
| Cost of revenue: | Cost of products and services | 17,601 | 22,289 | 60,735 | 58,105 |
| Cost of revenue: | Total cost of revenue | 40,319 | 44,002 | 128,258 | 120,613 |
| Cost of revenue: | Gross profit | 264,676 | 271,544 | 919,073 | 921,493 |
| Operating expenses: | Research and development | 65,749 | 65,982 | 198,477 | 194,327 |
| Operating expenses: | Sales and marketing | 85,071 | 86,163 | 272,786 | 270,191 |
| Operating expenses: | General and administrative | 75,585 | 72,307 | 221,783 | 212,814 |
| Operating expenses: | Restructuring charges/(credits) | 3,955 | -547 | 16,605 | 8,879 |
| Operating expenses: | Total operating expenses | 230,360 | 223,905 | 709,651 | 686,211 |
| Operating expenses: | Operating income | 34,316 | 47,639 | 209,422 | 235,282 |
| Other income/(expense): | Interest income/(expense), net | 3,453 | 4,111 | 12,595 | 10,316 |
| Other income/(expense): | Other income, net | 6,033 | 3,766 | 13,086 | 16,219 |
| Other income/(expense): | Total other income | 9,486 | 7,877 | 25,681 | 26,535 |
| Other income/(expense): | Income before income taxes | 43,802 | 55,516 | 235,103 | 261,817 |
| Other income/(expense): | Provision for income taxes | -14,588 | -8,974 | -56,754 | -54,979 |
| Other income/(expense): | Net income including noncontrolling interest | 29,214 | 46,542 | 178,349 | 206,838 |
| Other income/(expense): | Less: net income attributable to noncontrolling interest | -612 | -471 | -1,505 | -1,152 |
| Other income/(expense): | Net income attributable to Dolby Laboratories, Inc. | 28,602 | 46,071 | 176,844 | 205,686 |
| Net income per share: | Basic | 0.3 | 0.48 | 1.86 | 2.14 |
| Net income per share: | Diluted | 0.3 | 0.48 | 1.84 | 2.11 |
| Weighted-average shares outstanding: | Basic | 94,242 | 95,897 | 94,975 | 95,947 |
| Weighted-average shares outstanding: | Diluted | 94,518 | 96,900 | 95,859 | 97,537 |
Income Statement
Net income: — financial measures included in this release for the third quarters of fiscal 2026 and fiscal 2025: (in thousands)
| Fiscal Quarter Ended – June 26, 2026 | June 26, 2026 | Fiscal Quarter Ended – June 27, 2025 | June 27, 2025 | ||
|---|---|---|---|---|---|
| GAAP net income attributable to Dolby Laboratories, Inc. | 28,602 | 46,071 | |||
| Stock-based compensation (1) | 30,964 | 30,728 | |||
| Amortization of acquisition-related intangibles (2) | 9,705 | 10,016 | |||
| Restructuring charges/(credits) | 3,955 | -547 | |||
| Income tax adjustments | -8,077 | -10,606 | |||
| Non-GAAP net income attributable to Dolby Laboratories, Inc. | 65,149 | 75,662 | |||
| (1) Stock-based compensation included in above line items: | Cost of products and services | 440 | 420 | ||
| (1) Stock-based compensation included in above line items: | Research and development | 9,695 | 9,188 | ||
| (1) Stock-based compensation included in above line items: | Sales and marketing | 10,293 | 10,589 | ||
| (1) Stock-based compensation included in above line items: | General and administrative | 10,536 | 10,531 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Cost of licensing | 6,590 | 6,610 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Cost of products and services | 768 | 753 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Sales and marketing | 352 | 340 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | General and administrative | 1,554 | 1,872 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Other income, net | 441 | 441 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Diluted earnings per share: | Fiscal Quarter Ended | Fiscal Quarter Ended | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | GAAP diluted earnings per share | 0.3 | 0.48 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Stock-based compensation | 0.33 | 0.32 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Amortization of acquisition-related intangibles | 0.1 | 0.1 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Restructuring charges/(credits) | 0.04 | -0.01 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Income tax adjustments | -0.08 | -0.11 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Non-GAAP diluted earnings per share | 0.69 | 0.78 | ||
| (2) Amortization of acquisition-related intangibles included in above line items: | Weighted-average shares outstanding - diluted (in thousands) | 94,518 | 96,900 |
Income Statement
Diluted earnings per share: — versions of the estimated financial measures for the fourth quarter of fiscal 2026 and full year fiscal 2026 included in this release: (in millions)
| Q4 2026 – Low | Q4 2026 – High | Fiscal 2026 – Low | Fiscal 2026 – High | |
|---|---|---|---|---|
| GAAP diluted earnings per share (low - high end of range) | 0.78 | 0.93 | 2.62 | 2.77 |
| Stock-based compensation (low - high end of range) | 0.32 | 0.32 | 1.33 | 1.33 |
| Amortization of acquisition-related intangibles (low - high end of range) | 0.1 | 0.1 | 0.41 | 0.41 |
| Restructuring charges (low - high end of range) | 0.18 | 0.18 | ||
| Income tax adjustments (low - high end of range) | -0.07 | -0.07 | -0.29 | -0.29 |
| Non-GAAP diluted earnings per share (low - high end of range) | 1.13 | 1.28 | 4.25 | 4.4 |
Balance Sheet
June 26, 2026 — ) (in thousands)
| June 26, 2026 | September 26, 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 669,394 | 701,893 |
| Current assets: | Restricted cash | 69,492 | 91,468 |
| Current assets: | Short-term investments | 652 | 703 |
| Current assets: | Accounts receivable, net | 285,148 | 331,096 |
| Current assets: | Contract assets, net | 206,881 | 180,804 |
| Current assets: | Inventories, net | 30,768 | 30,424 |
| Current assets: | Prepaid expenses and other current assets | 63,706 | 51,873 |
| Current assets: | Total current assets | 1,326,041 | 1,388,261 |
| Current assets: | Long-term investments | 86,437 | 80,205 |
| Current assets: | Property, plant, and equipment, net | 459,115 | 470,608 |
| Current assets: | Operating lease right-of-use assets | 42,401 | 33,204 |
| Current assets: | Goodwill and intangible assets, net | 910,777 | 926,957 |
| Current assets: | Deferred taxes | 213,171 | 214,361 |
| Current assets: | Other non-current assets | 118,660 | 114,164 |
| Current assets: | Total assets | 3,156,602 | 3,227,760 |
| Current liabilities: | Accounts payable | 12,470 | 17,840 |
| Current liabilities: | Accrued liabilities | 360,407 | 369,256 |
| Current liabilities: | Income taxes payable | 8,928 | |
| Current liabilities: | Contract liabilities | 33,593 | 31,382 |
| Current liabilities: | Operating lease liabilities | 9,859 | 10,384 |
| Current liabilities: | Total current liabilities | 416,329 | 437,790 |
| Current liabilities: | Non-current contract liabilities | 23,463 | 29,687 |
| Current liabilities: | Non-current operating lease liabilities | 37,591 | 28,494 |
| Current liabilities: | Other non-current liabilities | 86,504 | 99,843 |
| Current liabilities: | Total liabilities | 563,887 | 595,814 |
| Stockholders’ equity: | Class A common stock | 52 | 54 |
| Stockholders’ equity: | Class B common stock | 40 | 40 |
| Stockholders’ equity: | Retained earnings | 2,598,923 | 2,634,980 |
| Stockholders’ equity: | Accumulated other comprehensive loss | -15,468 | -12,517 |
| Stockholders’ equity: | Total stockholders’ equity – Dolby Laboratories, Inc. | 2,583,547 | 2,622,557 |
| Stockholders’ equity: | Noncontrolling interest | 9,168 | 9,389 |
| Stockholders’ equity: | Total stockholders’ equity | 2,592,715 | 2,631,946 |
| Stockholders’ equity: | Total liabilities and stockholders’ equity | 3,156,602 | 3,227,760 |
Cash Flow
Fiscal Year-To-Date Ended — ) (in thousands)
| Fiscal Year-To-Date Ended – June 26, 2026 | Fiscal Year-To-Date Ended – June 27, 2025 | ||
|---|---|---|---|
| Operating activities: | Net income including noncontrolling interest | 178,349 | 206,838 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation and amortization | 70,842 | 65,829 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Stock-based compensation | 98,883 | 97,462 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Amortization of operating lease right-of-use assets | 7,889 | 8,193 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Provision for credit losses | 4,244 | 2,582 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Deferred income taxes | 1,542 | -9,146 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Share of net income of equity method investees, net of cash distributions | -7,602 | 1,845 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Other non-cash items affecting net income | -1,289 | -429 |
| Changes in operating assets and liabilities: | Accounts receivable, net | 1,489 | 15,234 |
| Changes in operating assets and liabilities: | Contract assets, net | -28,442 | -6,902 |
| Changes in operating assets and liabilities: | Inventories | 6,512 | 4,020 |
| Changes in operating assets and liabilities: | Operating lease right-of-use assets | -17,547 | -1,717 |
| Changes in operating assets and liabilities: | Prepaid expenses and other assets | -31,999 | 28,003 |
| Changes in operating assets and liabilities: | Accounts payable and accrued liabilities | 35,611 | -48,979 |
| Changes in operating assets and liabilities: | Income taxes, net | -2,771 | 1,895 |
| Changes in operating assets and liabilities: | Contract liabilities | 1,620 | -1,061 |
| Changes in operating assets and liabilities: | Operating lease liabilities | 9,036 | -8,237 |
| Changes in operating assets and liabilities: | Other non-current liabilities | -11,600 | -6,063 |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 314,767 | 349,367 |
| Investing activities: | Proceeds from sales of marketable securities | 15,911 | |
| Investing activities: | Proceeds from sale of assets held for sale | 16,881 | |
| Investing activities: | Purchases of property, plant, and equipment | -28,681 | -20,104 |
| Investing activities: | Business combinations, net of cash and restricted cash acquired, and other related payments | -1,362 | |
| Investing activities: | Purchases of intangible assets | -42,575 | |
| Investing activities: | Proceeds from sale of intangible assets | 16,623 | |
| Investing activities: | Net cash provided by/(used in) investing activities | -54,633 | 11,326 |
| Financing activities: | Proceeds from issuance of common stock | 24,685 | 38,681 |
| Financing activities: | Repurchase of common stock | -200,001 | -89,990 |
| Financing activities: | Payment of excise tax on repurchase of common stock | -261 | |
| Financing activities: | Payment of cash dividend | -102,659 | -95,010 |
| Financing activities: | Distributions to noncontrolling interest | -1,640 | -1,449 |
| Financing activities: | Shares repurchased for tax withholdings on vesting of restricted stock | -33,113 | -35,154 |
| Financing activities: | Net cash used in financing activities | -312,728 | -183,183 |
| Financing activities: | Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | -1,881 | 1,302 |
Full release
Dolby’s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing herein due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby’s future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Quarterly Report on Form
10-Q for the third quarter of fiscal 2026, to be filed on or around the date hereof.
Dolby is providing the following estimates for its fourth quarter of fiscal 2026:
Dolby is providing the following estimates for the full year of fiscal 2026:
Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss third quarter fiscal 2026 financial results for Dolby
Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, July 30, 2026.
The conference call can be accessed by registering online at
Dolby
Laboratories Q3 Fiscal Year 2026 Financial Results, at which time registrants will receive dial-in information as well as a conference ID.
A live audio webcast of the conference call will be available at http://investor.dolby.com where it will be archived for one year.
Non-GAAP
Financial Information
To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance.
We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:
Stock-based compensation expense
:
Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.
Amortization of acquisition-related intangibles
: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes... (truncated)le assets is excluded from
Non-GAAP
Net Income, the revenue generated from those assets is not excluded.
Restructuring charges or credits
: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.
Income tax adjustments
: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.
Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its
US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.
Forward-Looking Statements
Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the fourth quarter of fiscal
2026 and full year fiscal 2026, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified under the section captioned “Risk Factors” in its Quarterly Report on Form
10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed... (truncated)ments. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
About Dolby
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like
Dolby Atmos,
Dolby Vision,
Dolby Cinema, and
Dolby OptiView.
Dolby, Dolby Atmos, Dolby
Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.